OTC Markets OTCPK - Delayed Quote USD

Palatin Technologies, Inc. (PTNT)

0.1206
+0.0056
+(4.87%)
At close: May 20 at 3:59:43 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
350
4,490.0900
4,853.6780
1,468.4570
-188.5970
Cost of Revenue
0
97.6370
418.4700
217.5290
147.8400
Gross Profit
350
4,392.4530
4,435.2080
1,250.9280
-336.4370
Operating Expense
26,780.8200
34,670.4180
37,921.4130
37,839.3760
30,263.4720
Operating Income
-26,430.8200
-30,277.9650
-33,486.2050
-36,588.4480
-30,599.9090
Net Non Operating Interest Income Expense
-14.9110
-17.1140
-20.0130
-29.6820
-23.4400
Other Income Expense
3,117.7500
558.9660
4,794.4780
419.8310
-2,973.1460
Pretax Income
-23,327.9810
-29,736.1130
-28,711.7400
-36,198.2990
-33,596.4950
Tax Provision
--
0
-4,674.9990
0
--
Net Income Common Stockholders
-23,327.9810
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Diluted NI Available to Com Stockholders
-23,327.9810
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Basic EPS
-1.17
-2.02
-2.21
-3.79
-3.50
Diluted EPS
-1.17
-2.02
-2.21
-3.79
-3.50
Basic Average Shares
20,870.5750
14,697.0960
10,890.1590
9,543.7620
9,466.0040
Diluted Average Shares
20,870.5750
14,697.0960
10,890.1590
9,543.7620
9,466.0040
Total Operating Income as Reported
-23,531.2560
-22,496.1210
-32,458.8830
-36,588.4480
-33,384.1010
Total Expenses
26,780.8200
34,768.0550
38,339.8830
38,056.9050
30,411.3120
Net Income from Continuing & Discontinued Operation
-23,327.9810
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Normalized Income
-26,445.7310
-30,991.9910
-28,984.6466
-36,618.1300
-30,623.3490
Interest Expense
14.9110
17.1140
20.0130
29.6820
23.4400
Net Interest Income
-14.9110
-17.1140
-20.0130
-29.6820
-23.4400
EBIT
-23,313.0700
-29,718.9990
-28,691.7270
-36,168.6170
-33,573.0550
EBITDA
-23,025.1860
-29,379.9240
-28,403.3960
-36,041.9490
-33,521.9340
Reconciled Cost of Revenue
0
97.6370
418.4700
217.5290
147.8400
Reconciled Depreciation
287.8840
339.0750
288.3310
126.6680
51.1210
Net Income from Continuing Operation Net Minority Interest
-23,327.9810
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Total Unusual Items Excluding Goodwill
3,117.7500
1,255.8780
5,910.2430
419.8310
-2,973.1460
Total Unusual Items
3,117.7500
1,255.8780
5,910.2430
419.8310
-2,973.1460
Normalized EBITDA
-26,142.9360
-30,635.8020
-34,313.6390
-36,461.7800
-30,548.7880
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
0
0
962.3374
0
0
6/30/2021 - 10/15/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RIGL Rigel Pharmaceuticals, Inc.
20.12
+2.13%
 
GLMD Galmed Pharmaceuticals Ltd.
1.3700
+7.03%
 
PTIXW Protagenic Therapeutics, Inc.
0.0600
+23.71%
 
KRYS Krystal Biotech, Inc.
131.55
-0.56%
 
APVO Aptevo Therapeutics Inc.
0.3099
-0.03%
 
CNSP CNS Pharmaceuticals, Inc.
1.2900
0.00%
 
AZTR Azitra, Inc.
0.2950
+3.18%
 
PSTV Plus Therapeutics, Inc.
0.3175
-5.22%
 
CARM Carisma Therapeutics, Inc.
0.1831
-3.73%
 
ENVB Enveric Biosciences, Inc.
1.3500
-0.74%